-
Chinese (Simplified)
-
English
-
German
-
Korean
-
Spanish
Chinese (Simplified)
English
German
Korean
Spanish
Sign up for an account to enjoy easy online shopping and instant order tracking.
The antibody against c-MYC was raised in mouse using the Peptide sequence derived from C-terminal (aa. 410-432) of Human c-Myc conjugated with KLH. as the immunogen. Antibodies were produced from mice ascites by injecting mice with a monoclonal cell line which was fusioned by mouse spleen and SP2/0 myeloma cell. Spleen cells were isolated from mice by immunizing with synthetic peptide and KLH conjugates. This antibody has been validated on ELISA, WB.
The antibody against c-MYC was raised in mouse using the Peptide sequence derived from C-terminal (aa. 410-432) of Human c-Myc conjugated with KLH. as the immunogen. Antibodies were produced from mice ascites by injecting mice with a monoclonal cell line which was fusioned by mouse spleen and SP2/0 myeloma cell. Spleen cells were isolated from mice by immunizing with synthetic peptide and KLH conjugates. This antibody has been validated on ELISA, WB.
$297.00
| Cat.No | ADC-55766A | Clonality | Monoclonal |
|---|---|---|---|
| Host Species | Mouse | Target Name | c-MYC |
| Target Synonyms | c-myc | Form | Liquid |
| Species Reactivity | Human | Isotype | IgG1 |
| Storage Buffer | Supplied in mice ascites. | Application | ELISA, WB |
| Storage | Upon receipt |
| Immunogen Description | Peptide sequence derived from C-terminal (aa. 410-432) of Human c-Myc conjugated with KLH. | Immunogen Sequence | Complete sequences for the immunogen, target protein, and peptides are available upon request. |
|---|
Notification